8-K - ImmunityBio, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 23, 2026, ImmunityBio, Inc. (the “Company”) entered into a letter amendment (the “Convertible Note Amendm

Material Agreement

$505.0M

Source Document

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description of Exhibit 10.1* Amendment dated January 23, 2026 to the Second Amended and Restated

Exhibits Only

Exhibits (2)

10.1

EX-10.1

8-K